electroCore, Inc.
ECOR · XNASCIK 1560258fmd_0MKS5TBARRBS2T59SN2YTZ90GVManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jan 01, 2017 to Sep 30, 2026, 39 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1 | 1 | 2 | 3 | 5 | 9 | 16 | 25 | 32 |
| Cost of revenue | 1 | 1 | 1 | 2 | 1 | 2 | 3 | 4 | 4 |
| Gross profit | 0 | 0 | 1 | 2 | 4 | 7 | 13 | 21 | 28 |
| Research and development | 8 | 12 | 10 | 4 | 3 | 6 | 5 | 2 | – |
| Selling, general and administrative | 18 | 43 | 35 | 22 | 22 | 24 | 27 | 31 | 38 |
| Total operating expenses | 26 | 55 | 47 | 27 | 24 | 30 | 32 | 34 | 41 |
| Operating income | (26) | (55) | (46) | (25) | (20) | (23) | (19) | (12) | (13) |
| Interest expense | 6 | – | 0 | 0 | – | 0 | – | 0 | 0 |
| Interest and investment income | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
| Other non-operating income (expense) | (10) | (1) | 1 | 0 | 2 | 0 | 0 | 0 | (1) |
| Income before taxes | (36) | (56) | (45) | (25) | (18) | (23) | (19) | (12) | (14) |
| Income tax expense | – | 0 | 0 | (1) | (1) | (0) | (0) | (0) | 0 |
| Net income from continuing operations | – | (56) | (45) | (24) | (17) | (22) | (19) | (12) | (14) |
| Net income | (36) | (56) | (45) | (24) | (17) | (22) | (19) | (12) | (14) |
| Net income to common shareholders | – | – | – | – | (17) | (22) | (19) | – | – |